Neuland Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Neuland Laboratories has a total shareholder equity of ₹11.3B and total debt of ₹1.0B, which brings its debt-to-equity ratio to 8.9%. Its total assets and total liabilities are ₹16.7B and ₹5.3B respectively. Neuland Laboratories's EBIT is ₹4.3B making its interest coverage ratio 51.6. It has cash and short-term investments of ₹1.4B.
Key information
8.9%
Debt to equity ratio
₹1.01b
Debt
| Interest coverage ratio | 51.6x |
| Cash | ₹1.37b |
| Equity | ₹11.33b |
| Total liabilities | ₹5.32b |
| Total assets | ₹16.65b |
Recent financial health updates
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet
Mar 15Recent updates
There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet
Mar 15Can You Imagine How Elated Neuland Laboratories' (NSE:NEULANDLAB) Shareholders Feel About Its 391% Share Price Gain?
Feb 28Don't Ignore The Fact That This Insider Just Sold Some Shares In Neuland Laboratories Limited (NSE:NEULANDLAB)
Feb 12Neuland Laboratories Limited (NSE:NEULANDLAB) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 04Neuland Laboratories Limited's (NSE:NEULANDLAB) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Feb 03Read This Before Selling Neuland Laboratories Limited (NSE:NEULANDLAB) Shares
Jan 18
If You Like EPS Growth Then Check Out Neuland Laboratories (NSE:NEULANDLAB) Before It's Too Late
Jan 01Is Neuland Laboratories Limited (NSE:NEULANDLAB) Popular Amongst Insiders?
Dec 14Did Business Growth Power Neuland Laboratories' (NSE:NEULANDLAB) Share Price Gain of 117%?
Nov 26Financial Position Analysis
Short Term Liabilities: NEULANDLAB's short term assets (₹8.3B) exceed its short term liabilities (₹4.0B).
Long Term Liabilities: NEULANDLAB's short term assets (₹8.3B) exceed its long term liabilities (₹1.3B).
Debt to Equity History and Analysis
Debt Level: NEULANDLAB has more cash than its total debt.
Reducing Debt: NEULANDLAB's debt to equity ratio has reduced from 38.1% to 8.9% over the past 5 years.
Debt Coverage: NEULANDLAB's debt is well covered by operating cash flow (316.2%).
Interest Coverage: NEULANDLAB's interest payments on its debt are well covered by EBIT (51.6x coverage).